211 related articles for article (PubMed ID: 29289621)
1. High-dose of vitamin D supplement is associated with reduced susceptibility of monocyte-derived macrophages to dengue virus infection and pro-inflammatory cytokine production: An exploratory study.
Giraldo DM; Cardona A; Urcuqui-Inchima S
Clin Chim Acta; 2018 Mar; 478():140-151. PubMed ID: 29289621
[TBL] [Abstract][Full Text] [Related]
2. Effect of high doses of vitamin D supplementation on dengue virus replication, Toll-like receptor expression, and cytokine profiles on dendritic cells.
Martínez-Moreno J; Hernandez JC; Urcuqui-Inchima S
Mol Cell Biochem; 2020 Jan; 464(1-2):169-180. PubMed ID: 31758375
[TBL] [Abstract][Full Text] [Related]
3. Human macrophages differentiated in the presence of vitamin D3 restrict dengue virus infection and innate responses by downregulating mannose receptor expression.
Arboleda Alzate JF; Rodenhuis-Zybert IA; Hernández JC; Smit JM; Urcuqui-Inchima S
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005904. PubMed ID: 29020083
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Regulates the Expression of Immune and Stress Response Genes in Dengue Virus-infected Macrophages by Inducing Specific MicroRNAs.
Fernandez GJ; Castillo JA; Giraldo DM; Urcuqui-Inchima S
Microrna; 2021; 10(4):240-249. PubMed ID: 34939557
[TBL] [Abstract][Full Text] [Related]
5. Regulation of innate immune responses in macrophages differentiated in the presence of vitamin D and infected with dengue virus 2.
Castillo JA; Giraldo DM; Hernandez JC; Smit JM; Rodenhuis-Zybert IA; Urcuqui-Inchima S
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009873. PubMed ID: 34634046
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D modulates the expression of Toll-like receptors and pro-inflammatory cytokines without affecting Chikungunya virus replication, in monocytes and macrophages.
Valdés-López JF; Velilla P; Urcuqui-Inchima S
Acta Trop; 2022 Aug; 232():106497. PubMed ID: 35508271
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D-mediated attenuation of miR-155 in human macrophages infected with dengue virus: Implications for the cytokine response.
Arboleda JF; Fernandez GJ; Urcuqui-Inchima S
Infect Genet Evol; 2019 Apr; 69():12-21. PubMed ID: 30639520
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-induced LL-37 modulates innate immune responses of human primary macrophages during DENV-2 infection.
Castillo JA; Giraldo DM; Smit JM; Rodenhuis-Zybert IA; Urcuqui-Inchima S
Pathog Dis; 2022 May; 80(1):. PubMed ID: 35512569
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide acts synergistically with the dengue virus to induce monocyte production of platelet activating factor and other inflammatory mediators.
Kamaladasa A; Gomes L; Jeewandara C; Shyamali NL; Ogg GS; Malavige GN
Antiviral Res; 2016 Sep; 133():183-90. PubMed ID: 27476044
[TBL] [Abstract][Full Text] [Related]
10. Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures.
Duran A; Valero N; Mosquera J; Fuenmayor E; Alvarez-Mon M
Life Sci; 2017 Dec; 191():180-185. PubMed ID: 29055802
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D modulates inflammatory response of DENV-2-infected macrophages by inhibiting the expression of inflammatory-liked miRNAs.
Castillo JA; Urcuqui-Inchima S
Pathog Glob Health; 2023 Mar; 117(2):167-180. PubMed ID: 35850625
[TBL] [Abstract][Full Text] [Related]
12. The 1α,25-dihydroxy-vitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (Huh-7) cell lines and cytokine production in the infected monocytes.
Puerta-Guardo H; Medina F; De la Cruz Hernández SI; Rosales VH; Ludert JE; del Angel RM
Antiviral Res; 2012 Apr; 94(1):57-61. PubMed ID: 22387385
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effect of 1, 25 dihydroxy vitamin D
Jadhav NJ; Gokhale S; Seervi M; Patil PS; Alagarasu K
Int Immunopharmacol; 2018 Sep; 62():237-243. PubMed ID: 30032048
[TBL] [Abstract][Full Text] [Related]
14. Alpha-mangostin inhibits dengue virus production and pro-inflammatory cytokine/chemokine expression in dendritic cells.
Yongpitakwattana P; Morchang A; Panya A; Sawasdee N; Yenchitsomanus PT
Arch Virol; 2021 Jun; 166(6):1623-1632. PubMed ID: 33782775
[TBL] [Abstract][Full Text] [Related]
15. Chikungunya virus infection induces differential inflammatory and antiviral responses in human monocytes and monocyte-derived macrophages.
Felipe VLJ; Paula A V; Silvio UI
Acta Trop; 2020 Nov; 211():105619. PubMed ID: 32634389
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.
Rattanaburee T; Junking M; Panya A; Sawasdee N; Songprakhon P; Suttitheptumrong A; Limjindaporn T; Haegeman G; Yenchitsomanus PT
Antiviral Res; 2015 Dec; 124():83-92. PubMed ID: 26542647
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility and initial immune response of Tupaia belangeri cells to dengue virus infection.
Kayesh MEH; Kitab B; Sanada T; Hayasaka D; Morita K; Kohara M; Tsukiyama-Kohara K
Infect Genet Evol; 2017 Jul; 51():203-210. PubMed ID: 28392469
[TBL] [Abstract][Full Text] [Related]
18. Activity of vitamin D receptor agonists against dengue virus.
Jaratsittisin J; Xu B; Sornjai W; Weng Z; Kuadkitkan A; Li F; Zhou GC; Smith DR
Sci Rep; 2020 Jul; 10(1):10835. PubMed ID: 32616772
[TBL] [Abstract][Full Text] [Related]
19. Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development.
Marques RE; Guabiraba R; Del Sarto JL; Rocha RF; Queiroz AL; Cisalpino D; Marques PE; Pacca CC; Fagundes CT; Menezes GB; Nogueira ML; Souza DG; Teixeira MM
Immunology; 2015 Aug; 145(4):583-96. PubMed ID: 25939314
[TBL] [Abstract][Full Text] [Related]
20. Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression.
Tarasuk M; Songprakhon P; Chimma P; Sratongno P; Na-Bangchang K; Yenchitsomanus PT
Virus Res; 2017 Aug; 240():180-189. PubMed ID: 28864423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
